What is EUDA Health's operating income?

EUDA Health's total operating income in 2025 was -$2.48 million, based on the following breakdown: Total Gross Profit: $2.99 million Total Operating Expenses: $5.47 million

EUDA Health (EUDAW) Financials

$0.02 0.00 (-16.53%)

As of 01:19 PM Eastern

Compare

Annual Income Statements for EUDA Health

This table shows EUDA Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	0.86	-25	-10	-15	-2.77
Consolidated Net Income / (Loss)	0.90	-25	-10	-15	-2.77
Net Income / (Loss) Continuing Operations	1.62	-25	-8.43	-18	-2.77
Total Pre-Tax Income	1.67	-25	-8.43	-18	-2.73
Total Operating Income	-0.56	-12	-3.96	-17	-2.48
Total Gross Profit	1.25	0.87	0.84	0.76	2.99
Total Revenue	4.56	3.76	3.71	4.01	6.82
Operating Revenue	4.56	3.76	3.71	4.01	6.82
Total Cost of Revenue	3.31	2.89	2.86	3.25	3.83
Operating Cost of Revenue	3.31	2.89	2.86	3.25	3.83
Total Operating Expenses	1.81	13	4.80	18	5.47
Selling, General & Admin Expense	1.48	5.82	4.27	3.21	4.15
Marketing Expense	0.33	0.94	0.53	0.13	1.28
Research & Development Expense	-	-	0.00	0.00	0.00
Impairment Charge	0.00	1.14	0.00	15	0.04
Total Other Income / (Expense), net	2.23	-13	-4.47	-0.31	-0.25
Interest Expense	0.00	0.09	0.67	0.49	0.23
Other Income / (Expense), net	0.31	-13	-3.80	0.19	-0.02
Income Tax Expense	0.05	-0.02	0.00	-0.00	0.04
Net Income / (Loss) Discontinued Operations	-0.72	0.06	-1.60	2.25	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	0.04	-0.07	0.00	-0.03	0.01
Basic Earnings per Share	$0.09	($2.07)	($8.77)	($9.46)	($1.48)
Weighted Average Basic Shares Outstanding	9.25M	12.03M	1.15M	1.62M	1.87M
Diluted Earnings per Share	$0.09	($2.07)	($8.77)	($9.46)	($1.48)
Weighted Average Diluted Shares Outstanding	9.25M	12.03M	1.15M	1.62M	1.87M
Weighted Average Basic & Diluted Shares Outstanding	-	2.36M	24.63M	37.15M	1.89M

No quarterly income statements for EUDA Health are available.

This table details how cash moves in and out of EUDA Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-0.06	0.59	-0.59	0.04	0.11
Net Cash From Operating Activities	0.44	-1.53	-2.92	-2.03	-2.43
Net Cash From Continuing Operating Activities	-0.39	-0.09	-3.21	-2.03	-2.43
Net Income / (Loss) Continuing Operations	1.62	-25	-8.43	-18	-2.77
Consolidated Net Income / (Loss)	0.90	-25	-10	-15	-2.77
Net Income / (Loss) Discontinued Operations	-0.72	0.06	-1.60	2.25	0.00
Depreciation Expense	0.01	0.01	0.00	0.02	0.04
Amortization Expense	0.23	0.17	0.11	0.15	0.37
Non-Cash Adjustments To Reconcile Net Income	-1.92	9.10	3.27	16	0.11
Changes in Operating Assets and Liabilities, net	-0.33	16	1.83	-0.26	-0.18
Net Cash From Discontinued Operating Activities	0.83	-1.44	0.30	-0.01	0.00
Net Cash From Investing Activities	-0.36	-0.27	0.00	-0.15	-0.10
Net Cash From Continuing Investing Activities	-0.37	-0.25	0.00	-0.14	-0.10
Purchase of Property, Plant & Equipment	-0.00	0.00	0.00	-0.10	-0.08
Acquisitions	-	0.00	0.00	-0.02	-0.03
Divestitures	-	0.00	0.00	0.02	0.00
Other Investing Activities, net	-0.37	-0.25	0.00	-0.04	0.00
Net Cash From Discontinued Investing Activities	0.02	-0.02	0.00	-0.00	0.00
Net Cash From Financing Activities	-0.17	2.49	2.35	2.32	2.55
Net Cash From Continuing Financing Activities	0.71	1.01	2.72	2.07	2.55
Repayment of Debt	0.29	-1.51	0.21	-0.56	-0.60
Issuance of Debt	0.39	1.40	1.24	2.72	2.82
Issuance of Common Equity	0.00	0.50	0.79	0.05	0.10
Other Financing Activities, net	0.03	1.92	0.49	-0.15	0.23
Net Cash From Discontinued Financing Activities	-0.88	1.48	-0.37	0.26	0.00
Effect of Exchange Rate Changes	0.02	-0.10	-0.02	-0.10	0.09
Cash Interest Paid	0.11	0.02	0.02	0.06	0.01
Cash Income Taxes Paid	0.03	0.16	0.04	0.01	0.03

No quarterly cash flow statements for EUDA Health are available.

This table presents EUDA Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	8.00	26	1.31	1.70	1.72
Total Current Assets	4.35	25	0.72	0.76	1.04
Cash & Equivalents	0.19	0.06	0.19	0.24	0.35
Accounts Receivable	4.09	0.20	0.24	0.17	0.33
Inventories, net	-	-	0.00	0.13	0.00
Prepaid Expenses	0.07	0.16	0.19	0.23	0.36
Plant, Property, & Equipment, net	0.06	0.01	0.01	0.09	0.14
Total Noncurrent Assets	3.59	0.57	0.58	0.85	0.54
Noncurrent Note & Lease Receivables	1.85	0.02	0.03	0.03	0.02
Intangible Assets	0.29	-	0.00	0.34	0.16
Other Noncurrent Operating Assets	0.45	0.51	0.55	0.48	0.36
Total Liabilities & Shareholders' Equity	8.00	26	1.31	1.70	1.72
Total Liabilities	7.40	29	8.79	4.27	5.98
Total Current Liabilities	7.32	29	8.72	4.14	5.84
Short-Term Debt	0.35	3.40	3.93	2.01	4.35
Accounts Payable	2.82	0.00	0.00	0.03	0.01
Accrued Expenses	0.49	1.20	1.89	1.60	1.96
Customer Deposits	-	-	0.00	0.48	0.52
Current Deferred & Payable Income Tax Liabilities	0.31	0.12	0.21	0.26	0.09
Other Current Liabilities	3.35	22	0.82	0.73	0.92
Total Noncurrent Liabilities	0.08	0.02	0.08	0.13	0.15
Noncurrent Deferred & Payable Income Tax Liabilities	0.05	-	0.00	0.08	0.08
Other Noncurrent Operating Liabilities	0.03	0.02	0.08	0.05	0.07
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	0.60	-3.51	-7.48	-2.57	-4.27
Total Preferred & Common Equity	0.52	-3.52	-7.50	-2.55	-4.25
Total Common Equity	0.52	-3.52	-7.50	-2.55	-4.25
Common Stock	0.33	21	27	48	49
Retained Earnings	0.18	-25	-35	-50	-53
Accumulated Other Comprehensive Income / (Loss)	0.01	-0.13	-0.19	-0.26	-0.21
Noncontrolling Interest	0.08	0.01	0.02	-0.02	-0.01

No quarterly balance sheets for EUDA Health are available.

This table displays calculated financial ratios and metrics derived from EUDA Health's official financial filings.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	11,073,500.00	20,191,770.00	24,627,509.00	74,306,098.00	1,890,375.00
DEI Adjusted Shares Outstanding	11,073,500.00	20,191,770.00	1,231,375.00	3,715,305.00	1,890,375.00
DEI Earnings Per Adjusted Shares Outstanding	0.08	-1.23	-8.15	-4.13	-1.47
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	-17.42%	-1.54%	8.22%	70.04%
EBITDA Growth	0.00%	-215,023.76%	69.12%	-122.01%	87.68%
EBIT Growth	0.00%	-10,032.07%	68.86%	-120.83%	85.44%
NOPAT Growth	0.00%	-1,471.18%	67.58%	-337.64%	85.71%
Net Income Growth	0.00%	-2,870.92%	59.77%	-53.36%	82.02%
EPS Growth	0.00%	-2,400.00%	59.77%	-53.36%	82.02%
Operating Cash Flow Growth	0.00%	-443.94%	-91.11%	30.27%	-19.26%
Free Cash Flow Firm Growth	0.00%	0.00%	83.47%	-913.54%	90.15%
Invested Capital Growth	0.00%	-155.29%	-368.21%	10.58%	-29.35%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-
Gross Margin	27.42%	23.11%	22.72%	19.00%	43.88%
EBITDA Margin	-0.25%	-657.84%	-206.30%	-423.24%	-30.65%
Operating Margin	-12.28%	-324.61%	-106.87%	-432.19%	-36.33%
EBIT Margin	-5.40%	-662.41%	-209.52%	-427.56%	-36.61%
Profit (Net Income) Margin	19.75%	-662.79%	-270.77%	-383.73%	-40.58%
Tax Burden Percent	53.94%	99.68%	118.98%	87.24%	101.54%
Interest Burden Percent	-678.31%	100.38%	108.61%	102.87%	109.16%
Effective Tax Rate	2.78%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-71.28%	-5,009.31%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	811.13%	-6,018.76%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	221.33%	6,725.82%	0.00%	0.00%	0.00%
Return on Equity (ROE)	150.05%	1,716.51%	182.66%	306.18%	80.93%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-3.08%	-148.30%	-57.65%	-1,140.12%	-146.27%
Return on Assets (ROA)	11.26%	-148.38%	-74.51%	-1,023.26%	-162.12%
Return on Common Equity (ROCE)	130.34%	1,771.00%	183.16%	306.10%	80.56%
Return on Equity Simple (ROE_SIMPLE)	172.74%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.54	-8.55	-2.77	-12	-1.73
NOPAT Margin	-11.94%	-227.23%	-74.81%	-302.53%	-25.43%
Net Nonoperating Expense Percent (NNEP)	-882.41%	1,009.44%	169.12%	103.25%	74.20%
Return On Investment Capital (ROIC_SIMPLE)	-	8,161.25%	78.11%	2,150.47%	-2,102.08%
Cost of Revenue to Revenue	72.58%	76.89%	77.28%	81.00%	56.12%
SG&A Expenses to Revenue	32.39%	154.48%	115.19%	80.08%	60.84%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	39.71%	347.72%	129.59%	451.19%	80.21%
Earnings before Interest and Taxes (EBIT)	-0.25	-25	-7.77	-17	-2.50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.01	-25	-7.65	-17	-2.09
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	207.14	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	23.68	8.84	9.56	27.48	12.58
Price to Earnings (P/E)	124.84	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.80%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	141.68	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	23.74	9.56	10.57	27.91	13.17
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	243.76	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.59	-0.97	-0.53	-0.78	-1.02
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.27	-1.12	-0.78	-0.63	-0.41
Leverage Ratio	13.33	-11.57	-2.45	-0.30	-0.50
Compound Leverage Factor	-90.42	-11.61	-2.66	-0.31	-0.54
Debt to Total Capital	37.09%	-3,246.21%	-110.76%	-355.82%	5,271.63%
Short-Term Debt to Total Capital	37.09%	-3,246.21%	-110.76%	-355.82%	5,271.63%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	8.26%	-12.86%	-0.47%	3.37%	-15.24%
Common Equity to Total Capital	54.65%	3,359.07%	211.23%	452.45%	-5,156.38%
Debt to EBITDA	-30.73	-0.14	-0.51	-0.12	-2.08
Net Debt to EBITDA	-14.22	-0.11	-0.49	-0.10	-1.92
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.65	-0.40	-1.42	-0.17	-2.51
Net Debt to NOPAT	-0.30	-0.32	-1.35	-0.15	-2.31
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	8.81	-3.92	-58.75	-59.18	-38.70
Noncontrolling Interest Sharing Ratio	13.14%	-3.18%	-0.27%	0.02%	0.46%
Liquidity Ratios	-	-	-	-	-
Current Ratio	0.59	0.86	0.08	0.18	0.18
Quick Ratio	0.59	0.01	0.05	0.10	0.12
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-7.37	-1.22	-12	-1.22
Operating Cash Flow to CapEx	40,319.71%	0.00%	0.00%	-2,102.82%	-3,140.58%
Free Cash Flow to Firm to Interest Expense	0.00	-78.56	-1.82	-25.04	-5.32
Operating Cash Flow to Interest Expense	270.85	-16.28	-4.36	-4.13	-10.61
Operating Cash Flow Less CapEx to Interest Expense	270.18	-16.28	-4.36	-4.32	-10.95
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.57	0.22	0.28	2.67	4.00
Accounts Receivable Turnover	1.11	1.76	17.05	19.59	27.04
Inventory Turnover	0.00	0.00	0.00	0.00	58.07
Fixed Asset Turnover	80.08	109.98	406.01	84.94	60.62
Accounts Payable Turnover	1.17	0.00	0.00	239.11	191.22
Days Sales Outstanding (DSO)	327.58	207.83	21.41	18.63	13.50
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	6.29
Days Payable Outstanding (DPO)	311.01	0.00	0.00	1.53	1.91
Cash Conversion Cycle (CCC)	16.57	207.83	21.41	17.10	17.88
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	0.76	-0.42	-1.98	-1.77	-2.29
Invested Capital Turnover	5.97	22.05	-3.09	-2.14	-3.36
Increase / (Decrease) in Invested Capital	0.00	-1.19	-1.55	0.21	-0.52
Enterprise Value (EV)	108	36	39	112	90
Market Capitalization	108	33	35	110	86
Book Value per Share	$0.05	($0.17)	($0.30)	($0.10)	($0.11)
Tangible Book Value per Share	($0.07)	($0.17)	($0.30)	($0.12)	($0.12)
Total Capital	0.95	-0.10	-3.55	-0.56	0.08
Total Debt	0.35	3.40	3.93	2.01	4.35
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Net Debt	0.16	2.70	3.74	1.77	4.00
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.10	0.08
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.80	-1.39	-4.25	-1.61	-0.79
Debt-free Net Working Capital (DFNWC)	-2.61	-0.69	-4.06	-1.37	-0.45
Net Working Capital (NWC)	-2.96	-4.09	-7.99	-3.38	-4.80
Net Nonoperating Expense (NNE)	-1.44	16	7.26	3.26	1.03
Net Nonoperating Obligations (NNO)	0.16	3.08	5.50	0.80	1.98
Total Depreciation and Amortization (D&A)	0.23	0.17	0.12	0.17	0.41
Debt-free, Cash-free Net Working Capital to Revenue	-61.42%	-36.96%	-114.69%	-40.10%	-11.60%
Debt-free Net Working Capital to Revenue	-57.25%	-18.39%	-109.59%	-34.17%	-6.54%
Net Working Capital to Revenue	-65.01%	-108.77%	-215.67%	-84.23%	-70.32%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($8.80)	$0.00	($1.48)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	1.15M	0.00	1.87M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($8.80)	$0.00	($1.48)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	1.15M	0.00	1.87M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	1.23M	0.00	1.89M
Normalized Net Operating Profit after Tax (NOPAT)	-0.54	-7.76	-2.77	-1.81	-1.71
Normalized NOPAT Margin	-11.94%	-206.05%	-74.81%	-45.02%	-25.05%
Pre Tax Income Margin	36.62%	-664.90%	-227.57%	-439.84%	-39.97%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	-150.15	-265.88	-11.61	-34.79	-10.92
NOPAT to Interest Expense	-332.15	-91.21	-4.15	-24.62	-7.59
EBIT Less CapEx to Interest Expense	-150.82	-265.88	-11.61	-34.99	-11.26
NOPAT Less CapEx to Interest Expense	-332.82	-91.21	-4.15	-24.82	-7.93
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	-5.23%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-5.23%	0.00%	0.00%	0.00%

No quarterly metrics and ratios for EUDA Health are available.

Financials Breakdown Chart

EUDA Health Financials - Frequently Asked Questions

According to the most recent income statement we have on file, EUDA Health's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

EUDA Health's net income appears to be on a downward trend, with a most recent value of -$2.77 million in 2025, falling from $900.40 thousand in 2021. The previous period was -$15.39 million in 2024.

EUDA Health's total operating income in 2025 was -$2.48 million, based on the following breakdown:

Total Gross Profit: $2.99 million
Total Operating Expenses: $5.47 million

Over the last 4 years, EUDA Health's total revenue changed from $4.56 million in 2021 to $6.82 million in 2025, a change of 49.6%.

EUDA Health's total liabilities were at $5.98 million at the end of 2025, a 40.1% increase from 2024, and a 19.1% decrease since 2021.

In the past 4 years, EUDA Health's cash and equivalents has ranged from $57.54 thousand in 2022 to $345.15 thousand in 2025, and is currently $345.15 thousand as of their latest financial filing in 2025.

Over the last 4 years, EUDA Health's book value per share changed from 0.05 in 2021 to -0.11 in 2025, a change of -343.1%.

Related Companies

Financial statements for NASDAQ:EUDAW last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EUDA Health (EUDAW) Financials

Financials Breakdown Chart

EUDA Health Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

EUDA Health (EUDAW) Financials

Annual Income Statements for EUDA Health

Quarterly Income Statements for EUDA Health

Annual Cash Flow Statements for EUDA Health

Quarterly Cash Flow Statements for EUDA Health

Annual Balance Sheets for EUDA Health

Quarterly Balance Sheets for EUDA Health

Annual Metrics And Ratios for EUDA Health

Quarterly Metrics And Ratios for EUDA Health

Financials Breakdown Chart

EUDA Health Financials - Frequently Asked Questions

When does EUDA Health's fiscal year end?

How has EUDA Health's net income changed over the last 4 years?

What is EUDA Health's operating income?

How has EUDA Health's revenue changed over the last 4 years?

How much debt does EUDA Health have?

How much cash does EUDA Health have?

How has EUDA Health's book value per share changed over the last 4 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools